Molecular Dynamics Simulation of Atomic Interactions in the Vancomycin Binding Site

Area of Science:

• Microbiology
• Medicinal Chemistry
• Computational Biology

Background:

• Vancomycin is a critical antibiotic for treating Gram-positive infections, including methicillin-resistant Staphylococcus aureus (MRSA).
• It functions by inhibiting bacterial cell wall biosynthesis through binding to lipid II precursors.
• The asparagine residue at position 3 of vancomycin's structure is crucial for substrate recognition, despite not directly participating in dipeptide binding.

Purpose of the Study:

• To investigate the role of the third residue (asparagine) in vancomycin's binding interactions.
• To characterize the impact of substituting asparagine with aspartic acid (V_D) on vancomycin's binding affinity.
• To provide insights for developing novel glycopeptide antibiotics against vancomycin-resistant pathogens.

Main Methods:

• Molecular dynamic simulations were employed to study the binding of vancomycin and its analogue V_D.
• Simulations focused on interactions with l-Lys-d-Ala-d-Ala and l-Lys-d-Ala-d-Lac, key components of lipid II.
• Binding analysis utilized root-mean-square deviation (RMSD), 2D contour plots, hydrogen bond analysis, and free energy calculations.

Main Results:

• Aspartate substitution in V_D introduced a negative charge, altering the aglycon conformation.
• This conformational change minimized repulsive interactions, particularly with depsipeptide binding.
• The study identified specific binding interactions influenced by the third residue substitution.

Conclusions:

• The third residue of vancomycin significantly influences binding affinity and substrate recognition.
• Chemical modification at this position offers a strategy to enhance binding to vancomycin-resistant targets.
• Findings support the development of new glycopeptide antibiotics effective against vancomycin-resistant enterococci and S. aureus.